Citadel Advisors
NUVL icon

Citadel Advisors’s Nuvalent NUVL Stock Holding History

Citadel Advisors’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
10,300
-1,000
-9% -$102K ﹤0.01% 7537
2025
Q4 		$1.14M Buy
11,300
+6,100
+117% +$601K ﹤0.01% 7109
2025
Q3 		$450K Sell
5,200
-14,200
-73% -$1.12M ﹤0.01% 9398
2025
Q2 		$1.48M Sell
19,400
-3,600
-16% -$263K ﹤0.01% 6289
2025
Q1 		$1.63M Sell
23,000
-19,700
-46% -$1.54M ﹤0.01% 5925
2024
Q4 		$3.34M Buy
42,700
+31,700
+288% +$2.96M ﹤0.01% 4656
2024
Q3 		$1.13M Sell
11,000
-50,700
-82% -$4.21M ﹤0.01% 6644
2024
Q2 		$4.68M Sell
61,700
-11,100
-15% -$790K ﹤0.01% 3848
2024
Q1 		$5.47M Buy
72,800
+47,500
+188% +$3.78M ﹤0.01% 3812
2023
Q4 		$1.86M Buy
25,300
+9,800
+63% +$606K ﹤0.01% 5488
2023
Q3 		$713K Buy
15,500
+15,200
+5,067% +$675K ﹤0.01% 7302
2023
Q2 		$12.7K Sell
300
-10,100
-97% -$382K ﹤0.01% 13067
2023
Q1 		$271K Hold
10,400
– – ﹤0.01% 9578
2022
Q4 		$310K Buy
+10,400
New +$290K ﹤0.01% 9246

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors's NUVL Position: Q1 2026 in Review

Citadel Advisors reduced its Nuvalent (NUVL) stake by 15% in Q1 2026, selling an estimated $2.89M and leaving 166,773 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Citadel Advisors first reported a position in NUVL in Q1 2022 and has held it in 17 quarters since. The position peaked at $24.8M in Q3 2024. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Citadel Advisors held 166,773 shares of Nuvalent worth $17.1M as of Q1 2026.
  • Citadel Advisors sold 28,383 Nuvalent shares in Q1 2026, an estimated $2.89M.
  • Nuvalent made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2521 holding.
  • Citadel Advisors first reported a position in Nuvalent in Q1 2022 and has held it in 17 quarters since.
  • Citadel Advisors's Nuvalent position peaked at $24.8M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.